Gujarat

Zydus Hospira Oncology Private Limited (ZHOPL) is a 50%-50% joint venture (JV) company between Zydus Cadila. India and Hospira (a Pfizer company), manufacturing cytotoxic injectable products (Finished Products). With our past success in more than 30 regulatory inspections including USFDA. MHRA, PMDA. Japan etc... we now embark upon a journey of Self Reliant and making ZHOPL, a Centre of Excellence (CoE) for Oncology products.

Sardar Patel University comprises of 25 Postgraduate Departments, a constituent collage, and number of colleges affiliated to it. There are 14 PG Centers in the affiliated Colleges, linstitutions. The teaching programme covered at Postgraduate, Medicine, Homeopathy, Home Science, Law and Education includes Postgraduate Degree Courses, Postgraduate Diploma Courses, Diploma Courses, and Advanced Certificate Courses, Undergraduate Courses are taught in the colleges or institutes affiliated to the University.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
J A Sathwara¹, A M Bhandari^2
1* Department of Pharmacology, A.R.College of Pharmacy & G.H.Patel Institute of Pharmacy, Anand ,Gujarat
² Department of Clinical Pharmacy, A.R.College of Pharmacy & G.H.Patel Institute of Pharmacy, Anand ,Gujarat
*jignasa.sathwara@gmail.com

ABSTRACT
The development of drugs is costly for the Pharmaceutical companies and without the protection of Intellectual Properties, the formula for the drug can easily be duplicated and can be synthesized at cheaper cost. The U.S. intellectual property laws protect the rights of small inventors and large corporations alike to guarantee “the first to invent” the exclusive right to the patents. To solve the drug price inflation within the U.S., an initiative has been taken that drug patents are different from other innovations. Under the new plan, new drugs would be sold at generic prices upon FDA’s approval. New drugs will no longer be rewarded by net-profit from sales, but instead by Medical Innovation Prize Fund at a level of 0.5% of the gross domestic product, that provide money to developers of new products based upon the actual impact on health outcomes over ten years. Although patents protect the rights of the investors and courage innovations, there are certain ideas that should not been patented. Potentially lifesaving technologies should be separated from other type of innovations, and money making should not be the only inceptive for drug discovery. The number of worldwide who have access to medicines is low, an allowing patents on drugs, although increase the number of advancements in lifesaving technologies; it will decrease the number of people who access to them. International efforts should focus on allocating monetary motivation to provide people to access drugs.

(1).Crystalluria is the side effect associated with:
1. Quinolones 
2. Azoles
3. Sulphonamides
4. Taxol

In 2014, a Core Committee was constituted under the Chairmanship of Dr. VM Katoch by the Indian Health Ministry to revise National List of Essential Medicines (NLEM), 2011. In the process of revision of NLEM, several consultations were held across the country with experts from different domains.

Ajanta Pharma Ltd, a specialty pharmaceutical company engagi development, manufacture and marketing of quality finished dosaj in domestic and international markets, is looking for suita candidates for its Formulation facility at Dahej, Bharuch, Gujarat

Post : QC Officer/Executive (HPLC, GC, Micro LIMS)